Mika Kuroiwa

Title: Innovations by Mika Kuroiwa in Cell Nuclei Isolation

Introduction

Mika Kuroiwa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of cell biology, particularly in the area of antigen detection. His innovative methods have the potential to enhance the accuracy and reliability of cancer diagnostics.

Latest Patents

Kuroiwa holds a patent for a method titled "Method for isolating cell nuclei having enhanced antigenicity from fixed cells or FFPE tissue section, and antigen activator and kit therefor." This patent describes a pretreatment method for detecting the number of cells containing Ki-67 protein-positive nuclei using Ki-67 antibody. The method enhances the antigenicity of Ki-67 and other antigens, allowing for more objective quantification of Ki-67-positive cells. This advancement is crucial for determining therapy regimens based on accurate cell counts.

Career Highlights

Mika Kuroiwa is associated with Nitto Boseki Co., Ltd., where he continues to develop innovative solutions in the field of cell biology. His work has been instrumental in improving diagnostic techniques, which can lead to better patient outcomes.

Collaborations

Kuroiwa collaborates with talented individuals such as Natsuki Sato and Masatoshi Nakatsuji. These partnerships enhance the research and development efforts within his company, fostering an environment of innovation.

Conclusion

Mika Kuroiwa's contributions to the field of cell biology through his innovative patent demonstrate his commitment to advancing medical diagnostics. His work not only enhances the understanding of cell behavior but also paves the way for improved therapeutic strategies.